LR20

General Information


DRACP ID  DRACP05272

Peptide Name   LR20

Sequence  RILQQLLFIHFRIGCRHSRI

Sequence Length  20

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Cancer targeted peptides Membrane-targeted Cell-penetrating peptides



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Nanoparticle

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C114H188N38O24S

Absent amino acids  ADEKMNPTVWY

Common amino acids  IR

Mass  284614

Pl  12.5

Basic residues  6

Acidic residues  0

Hydrophobic residues  9

Net charge  6

Boman Index  -4086

Hydrophobicity  24.5

Aliphatic Index  136.5

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US 20100203611A1

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




Cppsite ID  1633

DRACP is developed by Dr.Zheng's team.